MedTrace Logo

Predictors and Prognostic Factors on the Acute Ischemic Stroke

NCT03122002 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1200

Last updated 2022-12-07

No results posted yet for this study

Summary

Through 5 years continuous observation of acute ischemic stroke patients in Neurology Department of Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, clinical data about emergency treatment (neurological score, examination and treatment), medical data after admission (neurological score, inspection, examination and treatment) and long-term prognosis (neurological score) was collected. The outcomes were set as the score scale, all blood test index and examination index of the research objects at specific period after illness. Through statistical analysis and comparison of different in-hospital clinical data in predicting the outcome of the patients, our study will provide more evidence-based solutions for the treatment and prediction of acute ischemic stroke.

Conditions

Interventions

DRUG

Drug Therapy

For this observation research, anti platelet drugs, statins and ect. would be used as clinical guidelines as usal, and statical ananysis of the relationship between these drugs and the final outcomes

DIAGNOSTIC_TEST

Routine Blood Test and Image Scan

Routine blood test(HCY, LDL and ect.) and image scan (DWI, DSA and ect.)

OTHER

Intravascular therapy

Intravascular therapy including thrombectomy

OTHER

Emergency Treatment

Emergency treatment including time to self-diagnosis of stroke, time to call for help, devices used to hospital and ect.

OTHER

Medical history

Medical history including hypertension, diabetes, hyperlipemia and ect.

Sponsors & Collaborators

  • Tongji Hospital

    lead OTHER

Principal Investigators

  • Wei Wang, PhD, MD · Tongji Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-03
Primary Completion
2021-12-31
Completion
2022-09-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03122002 on ClinicalTrials.gov